Jump to content

Lactic acidosis: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m Cleaned up using AutoEd
 
(37 intermediate revisions by 26 users not shown)
Line 1: Line 1:
{{short description|Metabolic medical condition}}
{{short description|Metabolic medical condition}}
{{Infobox medical condition (new)
{{Infobox medical condition (new)
| name = Lactic acidosis
| name = Lactic acid
| synonyms =
| synonyms =
| image = Lactic-acid-skeletal.svg
| image = Lactic-acid-skeletal.svg
| caption = [[Lactic acid|L-(+)-lactic acid]]
| caption = [[Lactic acid|L-(+)-lactic acid]]
| pronounce =
| pronounce =
| field =
| field =
| symptoms =
| symptom =
| complications =
| complications =
| onset =
| onset =
| duration =
| duration =
| types =
| types =
| causes =
| causes =
| risks =
| risks =
| diagnosis =
| diagnosis =
| differential =
| differential =
| prevention =
| prevention =
| treatment =
| treatment =
| medication =
| medication =
| prognosis =
| prognosis =
| frequency =
| frequency =
| deaths =
| deaths =
}}
}}
'''Lactic acidosis''' refers to the process leading to the production of lactate by anaerobic metabolism. It increases hydrogen ion concentration tending to the state of acidemia or low pH. The result can be detected with high levels of lactate and low levels of bicarbonate. This is usually considered the result of illness but also results from strenuous exercise. The effect on pH is moderated by the presence of respiratory compensation.
'''Lactic acidosis''' is a medical condition characterized by the buildup of [[Lactic acid|lactate]] (especially [[L-lactate]]) in the body, with formation of an excessively low [[pH]] in the bloodstream. It is a form of [[metabolic acidosis]], in which excessive acid accumulates due to a problem with the body's oxidative [[metabolism]].


Lactic acidosis is usually the result of tissue hypoxia which is not the same as arterial hypoxia. Adequate circulation of blood and perfusion of metabolizing tissue to meet demand is necessary to prevent tissue hypoxia. Lactic acidosis can also be the result of illnesses, medications, poisonings or inborn errors of metabolism that interfere directly with oxygen utilization by cells.<ref>{{Cite journal |last=Kraut |first=Jeffrey A. |last2=Madias |first2=Nicolaos E. |date=2014-12-11 |editor-last=Ingelfinger |editor-first=Julie R. |title=Lactic Acidosis |url=http://www.nejm.org/doi/10.1056/NEJMra1309483 |journal=New England Journal of Medicine |language=en |volume=371 |issue=24 |pages=2309–2319 |doi=10.1056/NEJMra1309483 |issn=0028-4793}}</ref>
Lactic acidosis is typically the result of an underlying acute or chronic medical condition, medication, or poisoning. The symptoms are generally attributable to these underlying causes, but may include [[nausea]], [[vomiting]], [[Kussmaul breathing]] (laboured and deep), and generalised weakness.

The symptoms are generally attributable to the underlying cause, but may include [[nausea]], [[vomiting]], shortness of breath, and generalised weakness.


The diagnosis is made on biochemical analysis of blood (often initially on [[arterial blood gas]] samples), and once confirmed, generally prompts an investigation to establish the underlying cause to treat the acidosis. In some situations, [[hemofiltration]] (purification of the blood) is temporarily required. In rare chronic forms of lactic acidosis caused by [[mitochondrial disease]], a specific diet or [[dichloroacetate]] may be used. The prognosis of lactic acidosis depends largely on the underlying cause; in some situations (such as [[sepsis|severe infections]]), it indicates an increased risk of death.
The diagnosis is made on biochemical analysis of blood (often initially on [[arterial blood gas]] samples), and once confirmed, generally prompts an investigation to establish the underlying cause to treat the acidosis. In some situations, [[hemofiltration]] (purification of the blood) is temporarily required. In rare chronic forms of lactic acidosis caused by [[mitochondrial disease]], a specific diet or [[dichloroacetate]] may be used. The prognosis of lactic acidosis depends largely on the underlying cause; in some situations (such as [[sepsis|severe infections]]), it indicates an increased risk of death.
Line 51: Line 53:
** [[Pyruvate dehydrogenase deficiency]]
** [[Pyruvate dehydrogenase deficiency]]
** [[Pyruvate carboxylase deficiency]]
** [[Pyruvate carboxylase deficiency]]
** [[Leigh syndrome]]<ref name=LeighSyndrome>{{cite journal |doi=10.1136/jnnp-2012-304426 |pmid=23772060 |title=A guide to diagnosis and treatment of Leigh syndrome |journal=Journal of Neurology, Neurosurgery & Psychiatry |volume=85 |issue=3 |pages=257–65 |year=2013 |last1=Baertling |first1=F |last2=Rodenburg |first2=R. J |last3=Schaper |first3=J |last4=Smeitink |first4=J. A |last5=Koopman |first5=W. J. H |last6=Mayatepek |first6=E |last7=Morava |first7=E |last8=Distelmaier |first8=F |s2cid=45323262 }}</ref>
** [[Leigh syndrome]]
* Drugs
* Drugs
**[[Linezolid]]<ref>{{cite journal |last1=Santini |first1=A |last2=Ronchi |first2=D |last3=Garbellini |first3=M |last4=Piga |first4=D |last5=Protti |first5=A |title=Linezolid-induced lactic acidosis: the thin line between bacterial and mitochondrial ribosomes. |journal=Expert Opinion on Drug Safety |date=July 2017 |volume=16 |issue=7 |pages=833–843 |doi=10.1080/14740338.2017.1335305 |pmid=28538105}}</ref>
** [[Linezolid]]<ref>{{cite journal |last1=Santini |first1=A |last2=Ronchi |first2=D |last3=Garbellini |first3=M |last4=Piga |first4=D |last5=Protti |first5=A |title=Linezolid-induced lactic acidosis: the thin line between bacterial and mitochondrial ribosomes. |journal=Expert Opinion on Drug Safety |date=July 2017 |volume=16 |issue=7 |pages=833–843 |doi=10.1080/14740338.2017.1335305 |pmid=28538105|s2cid=23123288 }}</ref>
** [[Paracetamol poisoning|Paracetamol/acetaminophen poisoning]]<ref>{{cite journal |last1=Shah |first1=AD |last2=Wood |first2=DM |last3=Dargan |first3=PI |title=Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. |journal=British Journal of Clinical Pharmacology |date=January 2011 |volume=71 |issue=1 |pages=20–8 |doi=10.1111/j.1365-2125.2010.03765.x |pmid=21143497|pmc=3018022 }}</ref>
** [[Paracetamol poisoning|Paracetamol/acetaminophen poisoning]]<ref>{{cite journal |last1=Shah |first1=AD |last2=Wood |first2=DM |last3=Dargan |first3=PI |title=Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. |journal=British Journal of Clinical Pharmacology |date=January 2011 |volume=71 |issue=1 |pages=20–8 |doi=10.1111/j.1365-2125.2010.03765.x |pmid=21143497|pmc=3018022 }}</ref>
**[[Metformin]]: this risk is low (less than 10 cases for 100,000 patient years), but the risk of [[metformin#Lactic acidosis|metformin-induced lactic acidosis]] (MALA) increases in certain situations where both the plasma levels of metformin are increased and lactate clearance is impaired.<ref>{{cite journal |last1=DeFronzo |first1=R |last2=Fleming |first2=GA |last3=Chen |first3=K |last4=Bicsak |first4=TA |title=Metformin-associated lactic acidosis: Current perspectives on causes and risk. |journal=Metabolism: Clinical and Experimental |date=February 2016 |volume=65 |issue=2 |pages=20–9 |doi=10.1016/j.metabol.2015.10.014 |pmid=26773926|doi-access=free }}</ref> The older related and now withdrawn drug [[phenformin]] carried a much higher risk of lactic acidosis.<ref name="pmid16567854">{{cite journal |last1=Fimognari |first1=F. L. |last2=Pastorelli |first2=R. |last3=Incalzi |first3=R. A. |title=Phenformin-Induced Lactic Acidosis in an Older Diabetic Patient: A recurrent drama (phenformin and lactic acidosis) |journal=Diabetes Care |volume=29 |issue=4 |pages=950–1 |year=2006 |pmid=16567854 |doi=10.2337/diacare.29.04.06.dc06-0012 |doi-access=free }}</ref>
** [[Metformin]]: this risk is low (less than 10 cases for 100,000 patient years), but the risk of [[metformin#Lactic acidosis|metformin-induced lactic acidosis]] (MALA) increases in certain situations where both the plasma levels of metformin are increased and lactate clearance is impaired.<ref>{{cite journal |last1=DeFronzo |first1=R |last2=Fleming |first2=GA |last3=Chen |first3=K |last4=Bicsak |first4=TA |title=Metformin-associated lactic acidosis: Current perspectives on causes and risk. |journal=Metabolism: Clinical and Experimental |date=February 2016 |volume=65 |issue=2 |pages=20–9 |doi=10.1016/j.metabol.2015.10.014 |pmid=26773926|doi-access=free }}</ref> The older related and now withdrawn drug [[phenformin]] carried a much higher risk of lactic acidosis.<ref name="pmid16567854">{{cite journal |last1=Fimognari |first1=F. L. |last2=Pastorelli |first2=R. |last3=Incalzi |first3=R. A. |title=Phenformin-Induced Lactic Acidosis in an Older Diabetic Patient: A recurrent drama (phenformin and lactic acidosis) |journal=Diabetes Care |volume=29 |issue=4 |pages=950–1 |year=2006 |pmid=16567854 |doi=10.2337/diacare.29.04.06.dc06-0012 |doi-access=free }}</ref>
**[[Isoniazid]] toxicity
** [[Isoniazid]] toxicity
**[[Propofol]]
** [[Propofol]]
** [[Epinephrine]]<ref>{{Cite journal|last1=Son|first1=Hee-Won|last2=Park|first2=Se-Hun|last3=Cho|first3=Hyun-Oh|last4=Shin|first4=Yong-Joon|last5=Son|first5=Jang-Ho|date=2016|title=Epinephrine-induced lactic acidosis in orthognathic surgery: a report of two cases|url=http://dx.doi.org/10.5125/jkaoms.2016.42.5.295|journal=Journal of the Korean Association of Oral and Maxillofacial Surgeons|volume=42|issue=5|pages=295–300|doi=10.5125/jkaoms.2016.42.5.295|pmid=27847739|issn=2234-7550|pmc=5104873}}</ref>
**[[Epinephrine]]
**[[Propylene glycol]] (D-lactic acidosis)
** [[Propylene glycol]] (D-lactic acidosis)
**[[Nucleoside]] [[reverse-transcriptase inhibitors]]
** [[Nucleoside]] [[reverse-transcriptase inhibitors]]
**[[Abacavir/dolutegravir/lamivudine]]<ref>{{Cite web|url=http://www.rxlist.com/triumeq-drug.htm|title=Triumeq (Abacavir, Dolutegravir, and Lamivudine Film-coated Tablets) Drug Information: Description, User Reviews, Drug Side Effects, Interactions – Prescribing Information at RxList|website=RxList|access-date=2016-03-25}}</ref>
** [[Abacavir/dolutegravir/lamivudine]]<ref>{{Cite web|url=http://www.rxlist.com/triumeq-drug.htm|title=Triumeq (Abacavir, Dolutegravir, and Lamivudine Film-coated Tablets) Drug Information: Description, User Reviews, Drug Side Effects, Interactions – Prescribing Information at RxList|website=RxList|access-date=2016-03-25}}</ref>
**[[Emtricitabine/tenofovir]]<ref>{{cite web |title=Truvada |url=https://www.drugs.com/cons/truvada.html }}</ref>
** [[Emtricitabine/tenofovir]]<ref>{{Cite web|url=https://www.drugs.com/cons/truvada.html|title=Truvada Advanced Patient Information|website=Drugs.com}}</ref>
**[[Potassium cyanide]] ([[cyanide poisoning]])
** [[Potassium cyanide]] ([[cyanide poisoning]])
**[[Fialuridine]]<ref>{{cite journal |last1=McKenzie |first1=Robin |last2=Fried |first2=Michael W. |last3=Sallie |first3=Richard |last4=Conjeevaram |first4=Hari |last5=Di Bisceglie |first5=Adrian M. |last6=Park |first6=Yoon |last7=Savarese |first7=Barbara |last8=Kleiner |first8=David |last9=Tsokos |first9=Maria |last10=Luciano |first10=Carlos |last11=Pruett |first11=Timothy |last12=Stotka |first12=Jennifer L. |last13=Straus |first13=Stephen E. |last14=Hoofnagle |first14=Jay H. |title=Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis B |journal=New England Journal of Medicine |volume=333 |issue=17 |pages=1099–105 |year=1995 |pmid=7565947 |doi=10.1056/NEJM199510263331702 }}</ref>
** [[Fialuridine]]<ref>{{cite journal |last1=McKenzie |first1=Robin |last2=Fried |first2=Michael W. |last3=Sallie |first3=Richard |last4=Conjeevaram |first4=Hari |last5=Di Bisceglie |first5=Adrian M. |last6=Park |first6=Yoon |last7=Savarese |first7=Barbara |last8=Kleiner |first8=David |last9=Tsokos |first9=Maria |last10=Luciano |first10=Carlos |last11=Pruett |first11=Timothy |last12=Stotka |first12=Jennifer L. |last13=Straus |first13=Stephen E. |last14=Hoofnagle |first14=Jay H. |title=Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis B |journal=New England Journal of Medicine |volume=333 |issue=17 |pages=1099–105 |year=1995 |pmid=7565947 |doi=10.1056/NEJM199510263331702 |doi-access=free }}</ref>
* Other
* Other
** Thiamine deficiency (especially during TPN)
** [[Thiamine deficiency]] (especially during [[Parenteral nutrition|TPN]])
** Impaired delivery of oxygen to cells in the tissues (e.g., from impaired blood flow (hypoperfusion))
** Impaired delivery of oxygen to cells in the tissues (e.g., from impaired blood flow (hypoperfusion))
** [[Hemorrhage|Bleeding]]
** [[Hemorrhage|Bleeding]]
** [[Polymyositis]]
** [[Polymyositis]]
** [[Alcohol#Toxicity|Ethanol toxicity]]
** [[Alcohol (drug)|Ethanol toxicity]]
** [[Sepsis]]
** [[Sepsis]]
** [[Shock (circulatory)|Shock]]
** [[Shock (circulatory)|Shock]]
Line 79: Line 81:
** [[Cancer]]s such as [[Non-Hodgkin lymphoma|Non-Hodgkin's]] and [[Burkitt lymphoma]]s
** [[Cancer]]s such as [[Non-Hodgkin lymphoma|Non-Hodgkin's]] and [[Burkitt lymphoma]]s
** [[Pheochromocytoma]]<ref name=KrautMadias2014/>
** [[Pheochromocytoma]]<ref name=KrautMadias2014/>
** [[Tumor lysis syndrome]]<ref>{{Cite journal|last=Darmon|first=Michael|last2=Malak|first2=Sandra|last3=Guichard|first3=Isabelle|last4=Schlemmer|first4=Benoit|date=July–September 2008|title=Acute tumor lysis syndrome: a comprehensive review|journal=Revista Brasileira de Terapia Intensiva|volume=20|issue=3|pages=278–285|doi=10.1590/S0103-507X2008000300011|issn=0103-507X|doi-access=free}}</ref>
** [[Tumor lysis syndrome]]<ref>{{Cite journal|last1=Darmon|first1=Michael|last2=Malak|first2=Sandra|last3=Guichard|first3=Isabelle|last4=Schlemmer|first4=Benoit|date=July–September 2008|title=Acute tumor lysis syndrome: a comprehensive review|journal=Revista Brasileira de Terapia Intensiva|volume=20|issue=3|pages=278–285|doi=10.1590/S0103-507X2008000300011|pmid=25307096|issn=0103-507X|doi-access=free}}</ref>
** D-lactic acidosis due to intestinal bacterial flora production in [[short gut syndrome]]
** D-lactic acidosis due to intestinal bacterial flora production in [[short gut syndrome]]


== Pathophysiology ==
== Pathophysiology ==
Glucose metabolism begins with [[glycolysis]], in which the molecule is broken down into pyruvate in ten enzymatic steps. A significant proportion of pyruvate is converted into lactate (usually 10:1). The human metabolism produces about 20 mmol/kg of lactate acid every 24 hours. This happens predominantly in tissues (especially muscle) that have high levels of the "A" isoform of the enzyme [[lactate dehydrogenase]] (LDHA), which predominantly converts [[pyruvate]] into lactate. The lactate is carried by the bloodstream to other tissues where it is converted at the expense of [[Adenosine triphosphate|ATP]] back to pyruvate by the "B" isoform of LDH (LDHB). Firstly there is [[gluconeogenesis]] in the liver (as well as the kidney and some other tissues), where pyruvate is converted into glucose; this is known as the [[Cori cycle]]. In addition, lactate moved to other tissues enters the [[citric acid cycle]] and eventually [[oxidative phosphorylation]], a process that yields ATP.<ref name=KrautMadias2014/>
Glucose metabolism begins with [[glycolysis]], in which the molecule is broken down into [[pyruvate]] in ten enzymatic steps. A significant proportion of pyruvate is converted into lactate (the blood lactate-to-pyruvate ratio is normally 10:1). The human metabolism produces about 20&nbsp;mmol/kg of lactic acid every 24 hours. This happens predominantly in tissues (especially muscle) that have high levels of the "A" isoform of the enzyme [[lactate dehydrogenase]] (LDHA), which predominantly converts [[pyruvate]] into lactate. The lactate is carried by the bloodstream to other tissues where it is converted back to pyruvate by the "B" isoform of LDH (LDHB). Firstly there is [[gluconeogenesis]] in the liver (as well as the kidney and some other tissues), where lactate is converted into pyruvate and then into glucose; this is known as the [[Cori cycle]]. In addition, pyruvate generated from lactate can be oxidized to [[acetyl-CoA]], which can enter the [[citric acid cycle]] to enable [[Adenosine triphosphate|ATP]] production by [[oxidative phosphorylation]].<ref name=KrautMadias2014/>


Elevations in lactate are either a consequence of increased production or of decreased metabolism. With regards to metabolism, this predominantly takes place in the liver (70%), which explains that lactate levels may be elevated in the setting of liver disease.<ref name=KrautMadias2014/>
Elevations in lactate are either a consequence of increased production or of decreased metabolism. With regards to metabolism, this predominantly takes place in the liver (70%), which explains that lactate levels may be elevated in the setting of liver disease.<ref name=KrautMadias2014/>
Line 98: Line 100:
| Venous blood || 4.5–19.8 || 0.5–2.2
| Venous blood || 4.5–19.8 || 0.5–2.2
|-
|-
| Arterial blood || 4.5–14.4 || 0.5–1.6
| Arterial blood || 4.5–14.4 || 0.5–1.6
|}
|}


Lactic acidosis is classically defined as an elevated lactate together with pH < 7.35 and bicarbonate below 20 mmol/l, but this is not required as lactic acidosis may exist together with other acid-base abnormalities that may affect these two parameters.<ref name=KrautMadias2014/>
Lactic acidosis is classically defined as an elevated lactate together with pH < 7.35 and bicarbonate below 20&nbsp;mmol/L, but this is not required as lactic acidosis may exist together with other acid-base abnormalities that may affect these two parameters.<ref name=KrautMadias2014/>


==Treatment==
==Treatment==
Line 108: Line 110:
Direct removal of lactate from the body (e.g. with [[hemofiltration]] or dialysis) is difficult, with limited evidence for benefit; it may not be possible to keep up with the lactate production.<ref name=KrautMadias2014/>
Direct removal of lactate from the body (e.g. with [[hemofiltration]] or dialysis) is difficult, with limited evidence for benefit; it may not be possible to keep up with the lactate production.<ref name=KrautMadias2014/>


Limited evidence supports the use of [[sodium bicarbonate]] solutions to improve the pH (which is associated with increased carbon dioxide generation and may reduce the [[calcium in biology|calcium]] levels).<ref name=KrautMadias2014/><ref>{{cite journal|last=Boyd|first=JH|author2=Walley, KR |title=Is there a role for sodium bicarbonate in treating lactic acidosis from shock?|journal=Current Opinion in Critical Care|date=Aug 2008|volume=14|issue=4|pages=379–83|doi=10.1097/MCC.0b013e3283069d5c|pmid=18614899}}</ref>
Limited evidence supports the use of [[sodium bicarbonate]] solutions to improve the pH (which is associated with increased carbon dioxide generation and may reduce the [[calcium in biology|calcium]] levels).<ref name=KrautMadias2014/><ref>{{cite journal|last=Boyd|first=JH|author2=Walley, KR |title=Is there a role for sodium bicarbonate in treating lactic acidosis from shock?|journal=Current Opinion in Critical Care|date=Aug 2008|volume=14|issue=4|pages=379–83|doi=10.1097/MCC.0b013e3283069d5c|pmid=18614899|s2cid=22613993}}</ref>


Lactic acidosis caused by inherited mitochondrial disorders (type B3) may be treated with a [[ketogenic diet]] and possibly with [[Dichloroacetic acid|dichloroacetate]] (DCA),<ref>{{cite journal|pmid=18647626|year=2008|last1=Stacpoole|first1=PW|last2=Kurtz|first2=TL|last3=Han|first3=Z|last4=Langaee|first4=T|title=Role of dichloroacetate in the treatment of genetic mitochondrial diseases|volume=60|issue=13–14|pages=1478–87|doi=10.1016/j.addr.2008.02.014|pmc=3746325|journal=Advanced Drug Delivery Reviews}}</ref> although this may be complicated by [[peripheral neuropathy]] and has a weak evidence base.<ref>{{cite journal | pmid=22513923 | year=2012 | last1=Pfeffer | first1=G | last2=Majamaa | first2=K | last3=Turnbull | first3=DM | last4=Thorburn | first4=D | last5=Chinnery | first5=PF | title=Treatment for mitochondrial disorders | volume=4 | issue=4 | pages=CD004426 | doi=10.1002/14651858.CD004426.pub3 | journal=The Cochrane Database of Systematic Reviews | editor1-last=Chinnery | editor1-first=Patrick F| pmc=7201312 }}</ref>
Lactic acidosis caused by inherited mitochondrial disorders (type B3) may be treated with a [[ketogenic diet]] and possibly with [[Dichloroacetic acid|dichloroacetate]] (DCA),<ref>{{cite journal|pmid=18647626|year=2008|last1=Stacpoole|first1=PW|last2=Kurtz|first2=TL|last3=Han|first3=Z|last4=Langaee|first4=T|title=Role of dichloroacetate in the treatment of genetic mitochondrial diseases|volume=60|issue=13–14|pages=1478–87|doi=10.1016/j.addr.2008.02.014|pmc=3746325|journal=Advanced Drug Delivery Reviews}}</ref> although this may be complicated by [[peripheral neuropathy]] and has a weak evidence base.<ref>{{cite journal | pmid=22513923 | year=2012 | last1=Pfeffer | first1=G | last2=Majamaa | first2=K | last3=Turnbull | first3=DM | last4=Thorburn | first4=D | last5=Chinnery | first5=PF | title=Treatment for mitochondrial disorders | volume=4 | issue=4 | pages=CD004426 | doi=10.1002/14651858.CD004426.pub3 | journal=The Cochrane Database of Systematic Reviews | editor1-last=Chinnery | editor1-first=Patrick F| pmc=7201312 }}</ref>
Line 115: Line 117:
Mild and transient elevations in lactate have limited impact on mortality, whereas sustained and severe lactate elevations are associated with a high mortality.<ref name=KrautMadias2014/>
Mild and transient elevations in lactate have limited impact on mortality, whereas sustained and severe lactate elevations are associated with a high mortality.<ref name=KrautMadias2014/>


The mortality of lactic acidosis in people taking metformin was previously reported to be 50%, but in more recent reports this was closer to 25%.<ref>{{cite journal|last1=Kajbaf|first1=F|last2=Lalau|first2=JD|title=Mortality rate in so-called "metformin-associated lactic acidosis": a review of the data since the 1960s.|journal=Pharmacoepidemiology and Drug Safety|date=November 2014|volume=23|issue=11|pages=1123–7|doi=10.1002/pds.3689|pmid=25079826}}</ref>
The mortality of lactic acidosis in people taking metformin was previously reported to be 50%, but in more recent reports this was closer to 25%.<ref>{{cite journal|last1=Kajbaf|first1=F|last2=Lalau|first2=JD|title=Mortality rate in so-called "metformin-associated lactic acidosis": a review of the data since the 1960s.|journal=Pharmacoepidemiology and Drug Safety|date=November 2014|volume=23|issue=11|pages=1123–7|doi=10.1002/pds.3689|pmid=25079826|s2cid=24262456}}</ref>


==Other animals==
==Other animals==


===Reptiles===
===Reptiles===
[[Reptiles]], which rely primarily on anaerobic energy metabolism ([[glycolysis]]) for intense movements, can be particularly susceptible to lactic acidosis. In particular, during the capture of large crocodiles, the animals' use of their glycolytic muscles often alter the blood's pH to a point where they are unable to respond to stimuli or move.<ref>{{cite book|author=Seymour R. S.|author2=Webb G. J. W.|author3=Bennett A. F.|author4=Bradford D. F.|year=1987|chapter=Chapter 26. Effect of capture on the physiology of ''Crocodylus porosus''|title=Wildlife Management: Crocodiles and Alligators|editor=Webb, G. J. W.|editor2=Manolis, S. C.|editor3=Whitehead, P. J.|pages=253–257|publisher=Surrey Beatty|location=Sydney|chapter-url=http://compphys.bio.uci.edu/bennett/pubs/80.pdf}}</ref> Cases are recorded in which particularly large crocodiles which put up extreme resistance to capture later died of the resulting pH imbalance.<ref name="croclist">[http://dml.cmnh.org/2001Apr/msg00485.html]. Accessed 31 January 2009.</ref>
[[Reptiles]], which rely primarily on anaerobic energy metabolism ([[glycolysis]]) for intense movements, can be particularly susceptible to lactic acidosis. In particular, during the capture of large crocodiles, the animals' use of their glycolytic muscles often alters the blood's pH to a point where they are unable to respond to stimuli or move.<ref>{{cite book|author=Seymour R. S.|author2=Webb G. J. W.|author3=Bennett A. F.|author4=Bradford D. F.|year=1987|chapter=Chapter 26. Effect of capture on the physiology of ''Crocodylus porosus''|title=Wildlife Management: Crocodiles and Alligators|editor=Webb, G. J. W.|editor2=Manolis, S. C.|editor3=Whitehead, P. J.|pages=253–257|publisher=Surrey Beatty|location=Sydney|chapter-url=http://compphys.bio.uci.edu/bennett/pubs/80.pdf}}</ref> Cases are recorded in which particularly large crocodiles which put up extreme resistance to capture later died of the resulting pH imbalance.<ref name="croclist">[http://dml.cmnh.org/2001Apr/msg00485.html] {{Webarchive|url=https://web.archive.org/web/20090502170222/http://dml.cmnh.org/2001Apr/msg00485.html|date=2009-05-02}}. Accessed 31 January 2009.</ref>


Certain turtle species have been found to be capable of tolerating high levels of lactic acid without suffering the effects of lactic acidosis. [[Painted turtle]]s [[hibernate]] buried in mud or underwater and do not resurface for the entire winter. As a result, they rely on [[anaerobic respiration]] to provide the majority of their energy needs.<ref name="Jackson 2002">{{cite journal|doi=10.1113/jphysiol.2002.024729|last=Jackson|first=Donald C.|title=Hibernating without oxygen: physiological adaptations of the painted turtle|journal=The Journal of Physiology |year=2002 |volume=543 |issue=3 |pages=731–737 |pmc=2290531 |pmid=12231634}}</ref> Adaptations in particular in the turtle's blood composition and shell allow it to tolerate high levels of lactic acid accumulation. In the [[Hypoxia (medical)|anoxic]] conditions where anaerobic respiration is dominant, calcium levels in the blood plasma increase.<ref name="Jackson 2002"/> This calcium serves as a buffer, reacting with the excess lactate to form the precipitate [[calcium lactate]]. This precipitate is suggested to be reabsorbed by the shell and skeleton, thereby removing it from the bloodstream; studies examining turtles that have been subjected to prolonged anoxic conditions have up to 45% of their lactate stored within their skeletal structure.<ref name="Jackson 2002"/>
Certain turtle species have been found to be capable of tolerating high levels of lactic acid without experiencing the effects of lactic acidosis. [[Painted turtle]]s [[hibernate]] buried in mud or underwater and do not resurface for the entire winter. As a result, they rely on [[lactic acid fermentation]] to provide the majority of their energy needs.<ref name="Jackson 2002">{{cite journal|doi=10.1113/jphysiol.2002.024729|last=Jackson|first=Donald C.|title=Hibernating without oxygen: physiological adaptations of the painted turtle|journal=The Journal of Physiology |year=2002 |volume=543 |issue=3 |pages=731–737 |pmc=2290531 |pmid=12231634}}</ref> Adaptations in particular in the turtle's blood composition and shell allow it to tolerate high levels of lactic acid accumulation. In the [[Hypoxia (medical)|anoxic]] conditions where fermentation is dominant, calcium levels in the blood plasma increase.<ref name="Jackson 2002"/> This calcium serves as a buffer, reacting with the excess lactate to form the precipitate [[calcium lactate]]. This precipitate is suggested to be reabsorbed by the shell and skeleton, thereby removing it from the bloodstream; studies examining turtles that have been subjected to prolonged anoxic conditions have up to 45% of their lactate stored within their skeletal structure.<ref name="Jackson 2002"/>


===Ruminants===
===Ruminants===
In [[ruminant]] livestock, the cause of clinically serious lactic acidosis is different from the causes described above.
In [[ruminant]] livestock, the cause of clinically serious lactic acidosis is different from the causes described above.


In domesticated ruminants, lactic acidosis may occur as a consequence of ingesting large amounts of grain, especially when the rumen population is poorly adapted to deal with grain.<ref name=Kimberling1988>Kimberling, C. V. 1988. Jensen and Swift's diseases of sheep. 3rd Ed. Lea & Fibiger, Philadelphia. 394 pp.</ref><ref name=Pugh2002>Pugh, D. G. 2002. Sheep and goat medicine. Saunders. 468 pp.</ref><ref name=Kahn2005>Kahn, C. M. (ed.) 2005. Merck veterinary manual. 9th Ed. Merck & Co., Inc., Whitehouse Station.</ref> Activity of various rumen organisms results in accumulation of various volatile fatty acids (normally, mostly acetic, propionic, and butyric acids), which are partially dissociated.<ref name=VanSoest1994>Van Soest, P. J. 1994. Nutritional ecology of the ruminant. 2nd Ed. Cornell Univ. Press, Ithaca. 476 pp.</ref> Although some lactate is normally produced in the rumen, it is normally metabolized by such organisms as ''Megasphaera elsdenii'' and, to a lesser extent, ''[[Selenomonas ruminantium]]'' and some other organisms. With high grain consumption, the concentration of dissociated organic acids can become quite high, resulting in rumen pH dropping below 6. Within this lower pH range, ''Lactobacillus'' spp. (producing lactate and hydrogen ions) are favored, and ''M. elsdenii'' and ''S. ruminantium'' are inhibited, tending to result in a considerable rise of lactate and hydrogen ion concentrations in the rumen fluid.<ref name=Nocek1997>{{cite journal | author = Nocek J. E. | year = 1997 | title = Bovine acidosis: implications on laminitis | journal = J. Dairy Sci. | volume = 80 | pages = 1005–1028 }}</ref> The [[Acid dissociation constant|pKa]] of lactic acid is low, about 3.9, versus, for example, 4.8 for acetic acid; this contributes to the considerable drop in rumen pH which can occur.<ref name=VanSoest1994/>
In domesticated ruminants, lactic acidosis may occur as a consequence of ingesting large amounts of grain, especially when the rumen population is poorly adapted to deal with grain.<ref name=Kimberling1988>Kimberling, C. V. 1988. Jensen and Swift's diseases of sheep. 3rd Ed. Lea & Fibiger, Philadelphia. 394 pp.</ref><ref name=Pugh2002>Pugh, D. G. 2002. Sheep and goat medicine. Saunders. 468 pp.</ref><ref name=Kahn2005>Kahn, C. M. (ed.) 2005. Merck veterinary manual. 9th Ed. Merck & Co., Inc., Whitehouse Station.</ref> Activity of various rumen organisms results in accumulation of various volatile fatty acids (normally, mostly acetic, propionic, and butyric acids), which are partially dissociated.<ref name=VanSoest1994>Van Soest, P. J. 1994. Nutritional ecology of the ruminant. 2nd Ed. Cornell Univ. Press, Ithaca. 476 pp.</ref> Although some lactate is normally produced in the rumen, it is normally metabolized by such organisms as ''Megasphaera elsdenii'' and, to a lesser extent, ''[[Selenomonas ruminantium]]'' and some other organisms. With high grain consumption, the concentration of dissociated organic acids can become quite high, resulting in rumen pH dropping below 6. Within this lower pH range, ''Lactobacillus'' spp. (producing lactate and hydrogen ions) are favored, and ''M. elsdenii'' and ''S. ruminantium'' are inhibited, tending to result in a considerable rise of lactate and hydrogen ion concentrations in the rumen fluid.<ref name=Nocek1997>{{cite journal | author = Nocek J. E. | year = 1997 | title = Bovine acidosis: implications on laminitis | journal = J. Dairy Sci. | volume = 80 | issue = 5 | pages = 1005–1028 | doi = 10.3168/jds.S0022-0302(97)76026-0 | pmid = 9178142 | doi-access = free }}</ref> The [[Acid dissociation constant|pKa]] of lactic acid is low, about 3.9, versus, for example, 4.8 for acetic acid; this contributes to the considerable drop in rumen pH which can occur.<ref name=VanSoest1994/>


Because of the high solute concentration of the rumen fluid under such conditions, considerable water is translocated from the blood to the rumen along the osmotic potential gradient, resulting in dehydration which cannot be relieved by drinking, and which can ultimately lead to [[Hypovolemia|hypovolemic shock]].<ref name=Kimberling1988/> As more lactate accumulates and rumen pH drops, the ruminal concentration of undissociated lactic acid increases. Undissociated lactic acid can cross the rumen wall to the blood,<ref>{{cite journal |last1=Owens |first1=FN |last2=Secrist |first2=DS |last3=Hill |first3=WJ |last4=Gill |first4=DR |title=Acidosis in cattle: a review |journal=Journal of Animal Science |volume=76 |issue=1 |pages=275–86 |year=1998 |pmid=9464909 |url=http://www.animalsciencepublications.org/publications/jas/articles/76/1/27 |doi=10.2527/1998.761275x }}</ref> where it dissociates, lowering blood pH. Both L and D isomers of lactic acid are produced in the rumen;<ref name=Kimberling1988/> these isomers are metabolized by different metabolic pathways, and activity of the principal enzyme involved in metabolism of the D isomer declines greatly with lower pH, tending to result in an increased ratio of D:L isomers as acidosis progresses.<ref name=Nocek1997/>
Because of the high solute concentration of the rumen fluid under such conditions, considerable water is translocated from the blood to the rumen along the osmotic potential gradient, resulting in dehydration which cannot be relieved by drinking, and which can ultimately lead to [[Hypovolemia|hypovolemic shock]].<ref name=Kimberling1988/> As more lactate accumulates and rumen pH drops, the ruminal concentration of undissociated lactic acid increases. Undissociated lactic acid can cross the rumen wall to the blood,<ref>{{cite journal |last1=Owens |first1=FN |last2=Secrist |first2=DS |last3=Hill |first3=WJ |last4=Gill |first4=DR |title=Acidosis in cattle: a review |journal=Journal of Animal Science |volume=76 |issue=1 |pages=275–86 |year=1998 |pmid=9464909 |url=http://www.animalsciencepublications.org/publications/jas/articles/76/1/27 |doi=10.2527/1998.761275x }}{{Dead link|date=June 2023 |bot=InternetArchiveBot |fix-attempted=yes }}</ref> where it dissociates, lowering blood pH. Both L and D isomers of lactic acid are produced in the rumen;<ref name=Kimberling1988/> these isomers are metabolized by different metabolic pathways, and activity of the principal enzyme involved in metabolism of the D isomer declines greatly with lower pH, tending to result in an increased ratio of D:L isomers as acidosis progresses.<ref name=Nocek1997/>


Measures for preventing lactic acidosis in ruminants include avoidance of excessive amounts of grain in the diet, and gradual introduction of grain over a period of several days, to develop a rumen population capable of safely dealing with a relatively high grain intake.<ref name=Kimberling1988/><ref name=Pugh2002/><ref name=Kahn2005/> Administration of lasalocid or monensin in feed can reduce risk of lactic acidosis in ruminants,<ref>{{cite journal |last1=Nagaraja |first1=TG |last2=Avery |first2=TB |last3=Bartley |first3=EE |last4=Galitzer |first4=SJ |last5=Dayton |first5=AD |title=Prevention of lactic acidosis in cattle by lasalocid or monensin |journal=Journal of Animal Science |volume=53 |issue=1 |pages=206–16 |year=1981 |pmid=7319937 |doi=10.2527/jas1981.531206x }}</ref> inhibiting most of the lactate-producing bacterial species without inhibiting the major lactate fermenters.<ref>{{cite journal |last1=Dennis |first1=SM |last2=Nagaraja |first2=TG |last3=Bartley |first3=EE |title=Effects of lasalocid or monensin on lactate-producing or -using rumen bacteria |journal=Journal of Animal Science |volume=52 |issue=2 |pages=418–26 |year=1981 |pmid=7275867 |doi=10.2527/jas1981.522418x }}</ref> Also, using a higher feeding frequency to provide the daily grain ration can allow higher grain intake without reducing the pH of the rumen fluid.<ref>{{cite journal | author = Kaufmann W | year = 1976 | title = Influence of the composition of the ration and the feeding frequency on ph-regulation in the rumen and on feed in-take in ruminants | journal = Livestock Prod. Sci. | volume = 3 | pages = 103–114 }}</ref>
Measures for preventing lactic acidosis in ruminants include avoidance of excessive amounts of grain in the diet, and gradual introduction of grain over a period of several days, to develop a rumen population capable of safely dealing with a relatively high grain intake.<ref name=Kimberling1988/><ref name=Pugh2002/><ref name=Kahn2005/> Administration of lasalocid or monensin in feed can reduce risk of lactic acidosis in ruminants,<ref>{{cite journal |last1=Nagaraja |first1=TG |last2=Avery |first2=TB |last3=Bartley |first3=EE |last4=Galitzer |first4=SJ |last5=Dayton |first5=AD |title=Prevention of lactic acidosis in cattle by lasalocid or monensin |journal=Journal of Animal Science |volume=53 |issue=1 |pages=206–16 |year=1981 |pmid=7319937 |doi=10.2527/jas1981.531206x }}</ref> inhibiting most of the lactate-producing bacterial species without inhibiting the major lactate fermenters.<ref>{{cite journal |last1=Dennis |first1=SM |last2=Nagaraja |first2=TG |last3=Bartley |first3=EE |title=Effects of lasalocid or monensin on lactate-producing or -using rumen bacteria |journal=Journal of Animal Science |volume=52 |issue=2 |pages=418–26 |year=1981 |pmid=7275867 |doi=10.2527/jas1981.522418x |doi-access=free }}</ref> Also, using a higher feeding frequency to provide the daily grain ration can allow higher grain intake without reducing the pH of the rumen fluid.<ref>{{cite journal | author = Kaufmann W | year = 1976 | title = Influence of the composition of the ration and the feeding frequency on ph-regulation in the rumen and on feed in-take in ruminants | journal = Livestock Prod. Sci. | volume = 3 | issue = 2 | pages = 103–114 | doi = 10.1016/0301-6226(76)90028-2 }}</ref>


Treatment of lactic acidosis in ruminants may involve intravenous administration of dilute sodium bicarbonate, oral administration of magnesium hydroxide, and/or repeated removal of rumen fluids and replacement with water (followed by reinoculation with rumen organisms, if necessary).<ref name=Kimberling1988/><ref name=Pugh2002/><ref name=Kahn2005/>
Treatment of lactic acidosis in ruminants may involve intravenous administration of dilute sodium bicarbonate, oral administration of magnesium hydroxide, and/or repeated removal of rumen fluids and replacement with water (followed by reinoculation with rumen organisms, if necessary).<ref name=Kimberling1988/><ref name=Pugh2002/><ref name=Kahn2005/>
Line 140: Line 142:
== External links ==
== External links ==
{{Medical resources
{{Medical resources
| DiseasesDB = 29145
| DiseasesDB = 29145
| ICD10 = {{ICD10|E|87|2|e|70}}
| ICD11 = {{ICD11|5C73.Y}}
| ICD9 = {{ICD9|276.2}}
| ICD10 = {{ICD10|E|87|2|e|70}}
| ICDO =
| ICD9 = {{ICD9|276.2}}
| OMIM =
| ICDO =
| MedlinePlus = 000391
| OMIM =
| MedlinePlus = 000391
| eMedicineSubj = article
| eMedicineSubj = article
| eMedicineTopic = 768159
| eMedicineTopic = 768159
| MeshID = D000140
| MeshID = D000140
}}
}}

Latest revision as of 18:29, 19 November 2024

Lactic acid
L-(+)-lactic acid
SpecialtyEndocrinology Edit this on Wikidata

Lactic acidosis refers to the process leading to the production of lactate by anaerobic metabolism. It increases hydrogen ion concentration tending to the state of acidemia or low pH. The result can be detected with high levels of lactate and low levels of bicarbonate. This is usually considered the result of illness but also results from strenuous exercise. The effect on pH is moderated by the presence of respiratory compensation.

Lactic acidosis is usually the result of tissue hypoxia which is not the same as arterial hypoxia. Adequate circulation of blood and perfusion of metabolizing tissue to meet demand is necessary to prevent tissue hypoxia. Lactic acidosis can also be the result of illnesses, medications, poisonings or inborn errors of metabolism that interfere directly with oxygen utilization by cells.[1]

The symptoms are generally attributable to the underlying cause, but may include nausea, vomiting, shortness of breath, and generalised weakness.

The diagnosis is made on biochemical analysis of blood (often initially on arterial blood gas samples), and once confirmed, generally prompts an investigation to establish the underlying cause to treat the acidosis. In some situations, hemofiltration (purification of the blood) is temporarily required. In rare chronic forms of lactic acidosis caused by mitochondrial disease, a specific diet or dichloroacetate may be used. The prognosis of lactic acidosis depends largely on the underlying cause; in some situations (such as severe infections), it indicates an increased risk of death.

Classification

[edit]

The CohenWoods classification categorizes causes of lactic acidosis as:[2]

  • Type A: Decreased tissue oxygenation (e.g., from decreased blood flow)
  • Type B

Signs and symptoms

[edit]

Lactic acidosis is commonly found in people who are unwell, such as those with severe heart and/or lung disease, a severe infection with sepsis, the systemic inflammatory response syndrome due to another cause, severe physical trauma, or severe depletion of body fluids.[3] Symptoms in humans include all those of typical metabolic acidosis (nausea, vomiting, generalized muscle weakness, and laboured and deep breathing).[4]

Causes

[edit]

The several different causes of lactic acidosis include:[citation needed]

Pathophysiology

[edit]

Glucose metabolism begins with glycolysis, in which the molecule is broken down into pyruvate in ten enzymatic steps. A significant proportion of pyruvate is converted into lactate (the blood lactate-to-pyruvate ratio is normally 10:1). The human metabolism produces about 20 mmol/kg of lactic acid every 24 hours. This happens predominantly in tissues (especially muscle) that have high levels of the "A" isoform of the enzyme lactate dehydrogenase (LDHA), which predominantly converts pyruvate into lactate. The lactate is carried by the bloodstream to other tissues where it is converted back to pyruvate by the "B" isoform of LDH (LDHB). Firstly there is gluconeogenesis in the liver (as well as the kidney and some other tissues), where lactate is converted into pyruvate and then into glucose; this is known as the Cori cycle. In addition, pyruvate generated from lactate can be oxidized to acetyl-CoA, which can enter the citric acid cycle to enable ATP production by oxidative phosphorylation.[3]

Elevations in lactate are either a consequence of increased production or of decreased metabolism. With regards to metabolism, this predominantly takes place in the liver (70%), which explains that lactate levels may be elevated in the setting of liver disease.[3]

In "type A" lactic acidosis, the production of lactate is attributable to insufficient oxygen for aerobic metabolism. If there is no oxygen available for the parts of the glucose metabolism that require oxygen (citric acid cycle and oxidative phosphorylation), excess pyruvate will be converted in excess lactate. In "type B" lactic acidosis the lactate accumulates because there is a mismatch between glycolysis activity and the remainder of glucose metabolism. Examples are situations where the sympathetic nervous system is highly active (e.g. severe asthma).[3] There is controversy as to whether elevated lactate in acute illness can be attributed to tissue hypoxia; there is limited empirical support for this theoretical notion.[15]

Diagnosis

[edit]

Acid-base disturbances such as lactic acidosis are typically first assessed using arterial blood gas tests. Testing of venous blood is also available as an alternative as they are effectively interchangeable.[3] Normally resulting lactate concentrations are in the range indicated below:[16]

mg/dL mM
Venous blood 4.5–19.8 0.5–2.2
Arterial blood 4.5–14.4 0.5–1.6

Lactic acidosis is classically defined as an elevated lactate together with pH < 7.35 and bicarbonate below 20 mmol/L, but this is not required as lactic acidosis may exist together with other acid-base abnormalities that may affect these two parameters.[3]

Treatment

[edit]

If elevated lactate is present in acute illness, supporting the oxygen supply and blood flow are key initial steps.[3] Some vasopressors (drugs that augment the blood pressure) are less effective when lactate levels are high, and some agents that stimulate the beta-2 adrenergic receptor can elevate the lactate further.[3]

Direct removal of lactate from the body (e.g. with hemofiltration or dialysis) is difficult, with limited evidence for benefit; it may not be possible to keep up with the lactate production.[3]

Limited evidence supports the use of sodium bicarbonate solutions to improve the pH (which is associated with increased carbon dioxide generation and may reduce the calcium levels).[3][17]

Lactic acidosis caused by inherited mitochondrial disorders (type B3) may be treated with a ketogenic diet and possibly with dichloroacetate (DCA),[18] although this may be complicated by peripheral neuropathy and has a weak evidence base.[19]

Prognosis

[edit]

Mild and transient elevations in lactate have limited impact on mortality, whereas sustained and severe lactate elevations are associated with a high mortality.[3]

The mortality of lactic acidosis in people taking metformin was previously reported to be 50%, but in more recent reports this was closer to 25%.[20]

Other animals

[edit]

Reptiles

[edit]

Reptiles, which rely primarily on anaerobic energy metabolism (glycolysis) for intense movements, can be particularly susceptible to lactic acidosis. In particular, during the capture of large crocodiles, the animals' use of their glycolytic muscles often alters the blood's pH to a point where they are unable to respond to stimuli or move.[21] Cases are recorded in which particularly large crocodiles which put up extreme resistance to capture later died of the resulting pH imbalance.[22]

Certain turtle species have been found to be capable of tolerating high levels of lactic acid without experiencing the effects of lactic acidosis. Painted turtles hibernate buried in mud or underwater and do not resurface for the entire winter. As a result, they rely on lactic acid fermentation to provide the majority of their energy needs.[23] Adaptations in particular in the turtle's blood composition and shell allow it to tolerate high levels of lactic acid accumulation. In the anoxic conditions where fermentation is dominant, calcium levels in the blood plasma increase.[23] This calcium serves as a buffer, reacting with the excess lactate to form the precipitate calcium lactate. This precipitate is suggested to be reabsorbed by the shell and skeleton, thereby removing it from the bloodstream; studies examining turtles that have been subjected to prolonged anoxic conditions have up to 45% of their lactate stored within their skeletal structure.[23]

Ruminants

[edit]

In ruminant livestock, the cause of clinically serious lactic acidosis is different from the causes described above.

In domesticated ruminants, lactic acidosis may occur as a consequence of ingesting large amounts of grain, especially when the rumen population is poorly adapted to deal with grain.[24][25][26] Activity of various rumen organisms results in accumulation of various volatile fatty acids (normally, mostly acetic, propionic, and butyric acids), which are partially dissociated.[27] Although some lactate is normally produced in the rumen, it is normally metabolized by such organisms as Megasphaera elsdenii and, to a lesser extent, Selenomonas ruminantium and some other organisms. With high grain consumption, the concentration of dissociated organic acids can become quite high, resulting in rumen pH dropping below 6. Within this lower pH range, Lactobacillus spp. (producing lactate and hydrogen ions) are favored, and M. elsdenii and S. ruminantium are inhibited, tending to result in a considerable rise of lactate and hydrogen ion concentrations in the rumen fluid.[28] The pKa of lactic acid is low, about 3.9, versus, for example, 4.8 for acetic acid; this contributes to the considerable drop in rumen pH which can occur.[27]

Because of the high solute concentration of the rumen fluid under such conditions, considerable water is translocated from the blood to the rumen along the osmotic potential gradient, resulting in dehydration which cannot be relieved by drinking, and which can ultimately lead to hypovolemic shock.[24] As more lactate accumulates and rumen pH drops, the ruminal concentration of undissociated lactic acid increases. Undissociated lactic acid can cross the rumen wall to the blood,[29] where it dissociates, lowering blood pH. Both L and D isomers of lactic acid are produced in the rumen;[24] these isomers are metabolized by different metabolic pathways, and activity of the principal enzyme involved in metabolism of the D isomer declines greatly with lower pH, tending to result in an increased ratio of D:L isomers as acidosis progresses.[28]

Measures for preventing lactic acidosis in ruminants include avoidance of excessive amounts of grain in the diet, and gradual introduction of grain over a period of several days, to develop a rumen population capable of safely dealing with a relatively high grain intake.[24][25][26] Administration of lasalocid or monensin in feed can reduce risk of lactic acidosis in ruminants,[30] inhibiting most of the lactate-producing bacterial species without inhibiting the major lactate fermenters.[31] Also, using a higher feeding frequency to provide the daily grain ration can allow higher grain intake without reducing the pH of the rumen fluid.[32]

Treatment of lactic acidosis in ruminants may involve intravenous administration of dilute sodium bicarbonate, oral administration of magnesium hydroxide, and/or repeated removal of rumen fluids and replacement with water (followed by reinoculation with rumen organisms, if necessary).[24][25][26]

References

[edit]
  1. ^ Kraut, Jeffrey A.; Madias, Nicolaos E. (2014-12-11). Ingelfinger, Julie R. (ed.). "Lactic Acidosis". New England Journal of Medicine. 371 (24): 2309–2319. doi:10.1056/NEJMra1309483. ISSN 0028-4793.
  2. ^ Woods, Hubert Frank; Cohen, Robert (1976). Clinical and biochemical aspects of lactic acidosis. Oxford: Blackwell Scientific. ISBN 0-632-09460-5.[page needed]
  3. ^ a b c d e f g h i j k l Kraut, Jeffrey A.; Madias, Nicolaos E. (11 December 2014). "Lactic Acidosis". New England Journal of Medicine. 371 (24): 2309–2319. doi:10.1056/NEJMra1309483. PMID 25494270.
  4. ^ MedlinePlus Encyclopedia: Lactic acidosis
  5. ^ Baertling, F; Rodenburg, R. J; Schaper, J; Smeitink, J. A; Koopman, W. J. H; Mayatepek, E; Morava, E; Distelmaier, F (2013). "A guide to diagnosis and treatment of Leigh syndrome". Journal of Neurology, Neurosurgery & Psychiatry. 85 (3): 257–65. doi:10.1136/jnnp-2012-304426. PMID 23772060. S2CID 45323262.
  6. ^ Santini, A; Ronchi, D; Garbellini, M; Piga, D; Protti, A (July 2017). "Linezolid-induced lactic acidosis: the thin line between bacterial and mitochondrial ribosomes". Expert Opinion on Drug Safety. 16 (7): 833–843. doi:10.1080/14740338.2017.1335305. PMID 28538105. S2CID 23123288.
  7. ^ Shah, AD; Wood, DM; Dargan, PI (January 2011). "Understanding lactic acidosis in paracetamol (acetaminophen) poisoning". British Journal of Clinical Pharmacology. 71 (1): 20–8. doi:10.1111/j.1365-2125.2010.03765.x. PMC 3018022. PMID 21143497.
  8. ^ DeFronzo, R; Fleming, GA; Chen, K; Bicsak, TA (February 2016). "Metformin-associated lactic acidosis: Current perspectives on causes and risk". Metabolism: Clinical and Experimental. 65 (2): 20–9. doi:10.1016/j.metabol.2015.10.014. PMID 26773926.
  9. ^ Fimognari, F. L.; Pastorelli, R.; Incalzi, R. A. (2006). "Phenformin-Induced Lactic Acidosis in an Older Diabetic Patient: A recurrent drama (phenformin and lactic acidosis)". Diabetes Care. 29 (4): 950–1. doi:10.2337/diacare.29.04.06.dc06-0012. PMID 16567854.
  10. ^ Son, Hee-Won; Park, Se-Hun; Cho, Hyun-Oh; Shin, Yong-Joon; Son, Jang-Ho (2016). "Epinephrine-induced lactic acidosis in orthognathic surgery: a report of two cases". Journal of the Korean Association of Oral and Maxillofacial Surgeons. 42 (5): 295–300. doi:10.5125/jkaoms.2016.42.5.295. ISSN 2234-7550. PMC 5104873. PMID 27847739.
  11. ^ "Triumeq (Abacavir, Dolutegravir, and Lamivudine Film-coated Tablets) Drug Information: Description, User Reviews, Drug Side Effects, Interactions – Prescribing Information at RxList". RxList. Retrieved 2016-03-25.
  12. ^ "Truvada Advanced Patient Information". Drugs.com.
  13. ^ McKenzie, Robin; Fried, Michael W.; Sallie, Richard; Conjeevaram, Hari; Di Bisceglie, Adrian M.; Park, Yoon; Savarese, Barbara; Kleiner, David; Tsokos, Maria; Luciano, Carlos; Pruett, Timothy; Stotka, Jennifer L.; Straus, Stephen E.; Hoofnagle, Jay H. (1995). "Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis B". New England Journal of Medicine. 333 (17): 1099–105. doi:10.1056/NEJM199510263331702. PMID 7565947.
  14. ^ Darmon, Michael; Malak, Sandra; Guichard, Isabelle; Schlemmer, Benoit (July–September 2008). "Acute tumor lysis syndrome: a comprehensive review". Revista Brasileira de Terapia Intensiva. 20 (3): 278–285. doi:10.1590/S0103-507X2008000300011. ISSN 0103-507X. PMID 25307096.
  15. ^ Garcia-Alvarez, Mercedes; Marik, Paul; Bellomo, Rinaldo (April 2014). "Stress hyperlactataemia: present understanding and controversy". The Lancet Diabetes & Endocrinology. 2 (4): 339–347. doi:10.1016/S2213-8587(13)70154-2. PMID 24703052.
  16. ^ Goldman, Lee; Schafer, Andrew (May 11, 2015). Goldman-Cecil Medicine (25 ed.). Elsevier. ISBN 978-1455750177.
  17. ^ Boyd, JH; Walley, KR (Aug 2008). "Is there a role for sodium bicarbonate in treating lactic acidosis from shock?". Current Opinion in Critical Care. 14 (4): 379–83. doi:10.1097/MCC.0b013e3283069d5c. PMID 18614899. S2CID 22613993.
  18. ^ Stacpoole, PW; Kurtz, TL; Han, Z; Langaee, T (2008). "Role of dichloroacetate in the treatment of genetic mitochondrial diseases". Advanced Drug Delivery Reviews. 60 (13–14): 1478–87. doi:10.1016/j.addr.2008.02.014. PMC 3746325. PMID 18647626.
  19. ^ Pfeffer, G; Majamaa, K; Turnbull, DM; Thorburn, D; Chinnery, PF (2012). Chinnery, Patrick F (ed.). "Treatment for mitochondrial disorders". The Cochrane Database of Systematic Reviews. 4 (4): CD004426. doi:10.1002/14651858.CD004426.pub3. PMC 7201312. PMID 22513923.
  20. ^ Kajbaf, F; Lalau, JD (November 2014). "Mortality rate in so-called "metformin-associated lactic acidosis": a review of the data since the 1960s". Pharmacoepidemiology and Drug Safety. 23 (11): 1123–7. doi:10.1002/pds.3689. PMID 25079826. S2CID 24262456.
  21. ^ Seymour R. S.; Webb G. J. W.; Bennett A. F.; Bradford D. F. (1987). "Chapter 26. Effect of capture on the physiology of Crocodylus porosus" (PDF). In Webb, G. J. W.; Manolis, S. C.; Whitehead, P. J. (eds.). Wildlife Management: Crocodiles and Alligators. Sydney: Surrey Beatty. pp. 253–257.
  22. ^ [1] Archived 2009-05-02 at the Wayback Machine. Accessed 31 January 2009.
  23. ^ a b c Jackson, Donald C. (2002). "Hibernating without oxygen: physiological adaptations of the painted turtle". The Journal of Physiology. 543 (3): 731–737. doi:10.1113/jphysiol.2002.024729. PMC 2290531. PMID 12231634.
  24. ^ a b c d e Kimberling, C. V. 1988. Jensen and Swift's diseases of sheep. 3rd Ed. Lea & Fibiger, Philadelphia. 394 pp.
  25. ^ a b c Pugh, D. G. 2002. Sheep and goat medicine. Saunders. 468 pp.
  26. ^ a b c Kahn, C. M. (ed.) 2005. Merck veterinary manual. 9th Ed. Merck & Co., Inc., Whitehouse Station.
  27. ^ a b Van Soest, P. J. 1994. Nutritional ecology of the ruminant. 2nd Ed. Cornell Univ. Press, Ithaca. 476 pp.
  28. ^ a b Nocek J. E. (1997). "Bovine acidosis: implications on laminitis". J. Dairy Sci. 80 (5): 1005–1028. doi:10.3168/jds.S0022-0302(97)76026-0. PMID 9178142.
  29. ^ Owens, FN; Secrist, DS; Hill, WJ; Gill, DR (1998). "Acidosis in cattle: a review". Journal of Animal Science. 76 (1): 275–86. doi:10.2527/1998.761275x. PMID 9464909.[permanent dead link]
  30. ^ Nagaraja, TG; Avery, TB; Bartley, EE; Galitzer, SJ; Dayton, AD (1981). "Prevention of lactic acidosis in cattle by lasalocid or monensin". Journal of Animal Science. 53 (1): 206–16. doi:10.2527/jas1981.531206x. PMID 7319937.
  31. ^ Dennis, SM; Nagaraja, TG; Bartley, EE (1981). "Effects of lasalocid or monensin on lactate-producing or -using rumen bacteria". Journal of Animal Science. 52 (2): 418–26. doi:10.2527/jas1981.522418x. PMID 7275867.
  32. ^ Kaufmann W (1976). "Influence of the composition of the ration and the feeding frequency on ph-regulation in the rumen and on feed in-take in ruminants". Livestock Prod. Sci. 3 (2): 103–114. doi:10.1016/0301-6226(76)90028-2.
[edit]